FDA’s approval of non-opioid pain pill could be game-changer

The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say Journavx is an important alternative because the power of opioids helped fuel an overdose epidemic and a surge in fentanyl use. Stephanie Stahl reports.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *